FVIII therapy
-
Final Data From the NuProtect Study Published on the Immunogenicity of Nuwiq® in Previously Untreated Patients With Severe Haemophilia A
LACHEN, Switzerland: Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated…
Read More »